BRIEF-Jeffs' Brands Enters Into A Definitive Agreement To Sell Key U.S. Assets To A Canadian Public Company-March 2024-www.financetom.com

BRIEF-Jeffs' Brands Enters Into A Definitive Agreement To Sell Key U.S. Assets To A Canadian Public Company

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Jeffs' Brands Enters Into A Definitive Agreement To Sell Key U.S. Assets To A Canadian Public Company

May 25, 2025 10:52 PM

April 30 (Reuters) - Jeffs Brands Ltd ( JFBR ):

* JEFFS' BRANDS ENTERS INTO A DEFINITIVE AGREEMENT TO SELL

KEY

U.S. ASSETS TO A CANADIAN PUBLIC COMPANY FOR AN APPROXIMATE

VALUATION OF $11.8 MILLION

* JEFFS BRANDS LTD ( JFBR ) - TO SELL SMART REPAIR PRO AND 49.1% SCI

SPARC

STAKE

* JEFFS BRANDS LTD ( JFBR ) - TRANSACTION VALUED AT CAD 17.125

MILLION FOR

SMART REPAIR PRO AND SNI STAKE

Source text:

Further company coverage:

Previous page： Amplitude Buys Command AI For Undisclosed Sum Next page： Immuneering Says Potential Pancreatic Cancer Treatment Gets FDA Orphan Drug Designation

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Amplitude Buys Command AI For Undisclosed Sum

Oct 15, 2024

10:00 AM EDT, 10/15/2024 (MT Newswires) -- Amplitude (AMPL) said Tuesday it has acquired Command AI, a startup that aims to make software easier to use by employing artificial intelligence capabilities. Financial terms of the deal were not disclosed. Amplitude said that with the acquisition, it plans to offer customized user assistance on its digital analytics platform through in-product nudges...

Immuneering Says Potential Pancreatic Cancer Treatment Gets FDA Orphan Drug Designation

Oct 15, 2024

09:16 AM EDT, 10/15/2024 (MT Newswires) -- Immuneering ( IMRX ) said Tuesday that its investigational drug IMM-1-104 has received orphan drug designation from the US Food and Drug Administration in the treatment of pancreatic cancer. The company said a phase 2a clinical trial to evaluate IMM-1-104 combined with chemotherapy in patients with advanced solid tumors, including pancreatic cancer, is...

Altair Engineering Insider Sold Shares Worth $9,523,390, According to a Recent SEC Filing

Oct 15, 2024

10:02 AM EDT, 10/15/2024 (MT Newswires) -- George J Christ, 10% Owner, on October 11, 2024, sold 100,000 shares in Altair Engineering ( ALTR ) for $9,523,390. Following the Form 4 filing with the SEC, Christ has control over a total of 774,950 shares of the company, with 774,950 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1701732/000112760224025428/xslF345X05/form4.xml Price: 95.26, Change: -0.24, Percent Change:...

US adds three Chinese companies to 'Unverified List' requiring additional export checks

Oct 15, 2024

(Corrects day of week in first paragraph to Tuesday) (Reuters) - The U.S. Commerce Department on Tuesday added three companies in China to a list of firms receiving U.S. exports that officials have been unable to inspect. Companies are placed on the Unverified List when U.S. export control officers cannot complete on-site visits to determine whether they can be trusted...